- Home
- CCCC vs RMMZ Comparison
CCCC vs RMMZ Comparison
Compare CCCC & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- RMMZ
- Stock Information
- Founded
- CCCC 2015
- RMMZ 2022
- Country
- CCCC United States
- RMMZ United States
- Employees
- CCCC N/A
- RMMZ N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- RMMZ Investment Managers
- Sector
- CCCC Health Care
- RMMZ Finance
- Exchange
- CCCC Nasdaq
- RMMZ Nasdaq
- Market Cap
- CCCC 104.4M
- RMMZ 122.3M
- IPO Year
- CCCC 2020
- RMMZ N/A
- Fundamental
- Price
- CCCC $2.26
- RMMZ $13.96
- Analyst Decision
- CCCC Buy
- RMMZ
- Analyst Count
- CCCC 3
- RMMZ 0
- Target Price
- CCCC $12.00
- RMMZ N/A
- AVG Volume (30 Days)
- CCCC 2.0M
- RMMZ 25.6K
- Earning Date
- CCCC 08-04-2025
- RMMZ 01-01-0001
- Dividend Yield
- CCCC N/A
- RMMZ 7.33%
- EPS Growth
- CCCC N/A
- RMMZ N/A
- EPS
- CCCC N/A
- RMMZ 0.82
- Revenue
- CCCC $39,783,000.00
- RMMZ N/A
- Revenue This Year
- CCCC N/A
- RMMZ N/A
- Revenue Next Year
- CCCC N/A
- RMMZ N/A
- P/E Ratio
- CCCC N/A
- RMMZ $19.41
- Revenue Growth
- CCCC 98.56
- RMMZ N/A
- 52 Week Low
- CCCC $1.09
- RMMZ $12.92
- 52 Week High
- CCCC $7.36
- RMMZ $16.99
- Technical
- Relative Strength Index (RSI)
- CCCC 60.73
- RMMZ 42.39
- Support Level
- CCCC $2.15
- RMMZ $14.09
- Resistance Level
- CCCC $2.53
- RMMZ $14.20
- Average True Range (ATR)
- CCCC 0.28
- RMMZ 0.09
- MACD
- CCCC 0.02
- RMMZ -0.01
- Stochastic Oscillator
- CCCC 62.13
- RMMZ 30.95
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.